Collective Health
-88%
est. 2Y upside i
Health benefits administration platform for self-funded employers
Rank
#3687
Sector
HealthTech
Est. Liquidity
~4Y
Data Quality
Data: LowEquity upside is deeply negative (-88% expected) due to a stale high valuation, severe preference overhang ($719M vs $1.5B), and strong competitive threats from incumbents.
Last updated: July 21, 2026
Revenue grows to $197M and exit multiple expands to 4x due to a favorable IPO window or category leadership. Exit value $789M, but preference overhang and dilution reduce upside to -47%.
Revenue grows to $197M but exit multiple converges to 2.5x, in line with public comps. Exit value $493M. After 20% dilution, common stock returns -87%.
Multiple compresses to 1.5x, exit value $296M below $719M liquidation preference. Common stock recovers -100% due to preference stack.
Preference Stack Risk
severeFunding Intensity
50300%Total funding $719M represents 48% of the $1.5B valuation, meaning common stock has limited recovery in a downside exit.
Dilution Risk
highWith no recent funding round and likely cash burn, a down round or significant raise is probable within 24 months, diluting common shareholders by an estimated 20%.
Secondary Liquidity
noneNo secondary market is indicated; liquidity will rely on an IPO or acquisition, which is uncertain.
Questions to Ask at the Interview
Strategic questions based on Collective Health's data — designed to show you've done your homework.
- 1
“What is Collective Health's path to profitability given the high burn and competitive pressure from incumbents like Accolade?”
- 2
“How does the per-employee-per-month pricing model scale with employer size and what is the long-term unit economics?”
- 3
“Given the Series F was in 2021, what is the company's plan for future funding and how does that affect my equity ownership?”
Community
Valuation Sentiment
Our model estimates -88% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.